drugset / Trial / NCT01003171

Pharmacokinetics of MCS in Healthy Volunteers

NCT01003171 ↗

Phase 1 Unknown 12 enrolled Health Ever Bio-Tech Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This study is to examine the pharmacokinetics, absorption and serum concentrations of MCS and other components after once-daily oral dosing of MCS.

Timeline

Start
2011-08
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MCS-2 Unknown 30 mg Oral

Indications

No indication recorded.